Bolivia Medical Device Registration vs Reinscripcion: Validity, Renewal and Number Retention

1. Key takeaways

A Bolivian sanitary registration for medical devices is valid for 5 years from the date of issuance (Section 3.1.5 of the manual). Reinscripción — the re-registration of the product — may be requested before expiry, or within 30 business days after the five-year term ends, and the original registration remains valid while the re-registration is being processed. The key structural difference between the two procedures is that re-registration can retain the original registration number, whereas a lapsed registration that misses the window must be handled as a new application. GRZAN’s assessment is that continuity of the registration number carries real commercial value in Bolivia: the number is printed on packaging, embedded in tender records, and loaded into hospital procurement systems, so a newly issued number creates practical friction across distribution channels.

The 30 business day window is counted from the date the five-year term ends, which makes the expiry date itself a compliance deadline rather than an administrative footnote. Because the window is short in working-day terms — roughly six weeks of calendar time — a re-registration dossier that is only started after expiry cannot realistically be completed, translated, and paid for inside it. The workable operating model is therefore asymmetric: preparation happens while the current registration is still valid, and the formal request is filed either before expiry or in the earliest days of the grace window, so that the continuity guarantee attaches to a file that is already complete.

2. Legal basis

The four provisions cited above divide the compliance workload into two tracks. Section 3.1.5 and Chapter 3 govern the product track — the five-year validity of the sanitary registration and the re-registration procedure itself. Section 5.7.2 governs the corporate track — the annual review of the registration holder, which runs on a separate calendar. Resolución Ministerial N° 0265 supplies the fee schedule for both tracks, and the manual must always be checked in the version currently published on the AGEMED website.

Section 5.7.2 deserves separate attention in the compliance calendar because its consequences are broader than its profile. The annual review of the registration holder is assessed against a fixed date — December 31 — and a lapsed holder review affects the validity of the entire portfolio, including registrations that are years away from their own expiry. Importers holding registrations on behalf of foreign manufacturers should treat the holder’s own corporate standing as part of product compliance, and manufacturers selecting Bolivian partners should verify the partner’s annual review record before appointing them as the registration holder for a new product line.

3. Expert insights

Insight 1: the 30 business day window is a grace period, not a recommended schedule. The legal effect of the window is that the original registration stays valid while re-registration is under processing, but it does not remove expiry risk. Once the 30 business days pass without a filed re-registration, the product stands without a valid registration, and both sales and imports must stop immediately. A distributor network that continues shipping during a lapse is exposed, and recovery requires a full new application rather than a continuation.

Insight 2: re-registration and the annual review are two parallel obligations. Re-registration targets the product and runs on a 5 year cycle; the annual review targets the company, and its fixed milestone is December 31 of each year (Section 5.7.2). A failure of the holder’s annual review affects every product registration under that holder’s name, and this effect is independent of any individual product’s expiry date. Managing both obligations on a single calendar is the most common root cause of lapses observed in practice.

Insight 3: re-registration of unsold products still carries a fee obligation. Public operating guidance from the pharmaceutical field indicates that products never placed on the market during their five-year validity must still pay the registration fee upon re-registration and retain the original number. Device projects should budget with the same prudence (practical estimate: the specific treatment for devices must be confirmed with AGEMED before the budget is fixed).

4. Practical recommendations

1. Build an expiry calendar for the whole certificate portfolio and restart dossier preparation 3 months before each expiry (practical estimate).
2. Manage the annual review and product re-registration as separate workstreams, so that one calendar never silently covers two different obligations.
3. Keep the value judgment on number retention inside the budget: where the original number already appears in tender records, re-registration is worth more economically than a new application.

In portfolio terms, the cheapest compliance decision is the one made twelve months early. Dossier documents — certificates of free sale, quality system certificates, labelling artwork — age at different speeds, and remanufacturing them after expiry typically costs more than refreshing them on schedule. Companies operating several registrations in Bolivia should treat the expiry calendar as a rolling production plan rather than a passive list of dates.

Number retention also matters commercially beyond tenders. Hospital procurement systems, distribution agreements, and post-market records all reference the sanitary registration number, and every change of number propagates into document updates across the supply chain. When the value of continuity is quantified — reprinting, requalification, re-entry into tender databases — the modest official fee of a timely re-registration under Resolución Ministerial N° 0265 compares very favourably with the friction of a new number, which is why GRZAN treats the re-registration calendar as a commercial instrument and not only as a regulatory duty.

5. Verification checklist

• □ Confirm the five-year expiry date is recorded in a calendar with advance reminders
• □ Confirm that re-registration can retain the original registration number
• □ Confirm the holder’s annual review status for the current December 31 cycle is complete
• □ Confirm re-registration documents have been remade under the current manual version, not the previous one
• □ Confirm the fee treatment for re-registration of unsold products has been clarified with AGEMED

GRZAN registration support. GRZAN provides medical device registration and re-registration support in Bolivia for manufacturers, importers, and authorized representatives, covering expiry management, dossier renewal, and coordination with AGEMED. For project inquiries, contact info@grzanglobal.com.

Regulatory information verified as of October 29, 2026.